Back
New CentoXome

Turning Years Into Days

It takes approx. 7 years to diagnose a patient with a rare disease. With NEW CentoXome®, you can turn those years into days.

Read More

CENTOGENE - Revolutionising Genetic Solutions

Explore how CENTOGENE is revolutionizing genetic solutions for patients worldwide

Know More

With the CentoKit-19™ You Perform a Coronavirus PCR Test by Yourself or Under Supervision of Trained Personnel –

With the CentoKit-19™ You Perform a Coronavirus PCR Test by Yourself or Under Supervision of Trained Personnel –

Reliable, quick and comfortable at home or at your workplace.

More Info

Coronavirus Tests by CENTOGENE

Coronavirus Tests by CENTOGENE

At a Test Center near you, at home or customized for your business, school or event

Read More

Our goal: providing precise medical diagnosis of inherited diseases at the earliest possible moment; transforming medical expertise and analytical information into actionable results for physicians, patients, and pharmaceutical partners.

Our commitment: life-long support for our patients and partners - driven by the continuous improvement of our diagnostic quality and therapeutic options for individual patients.

CENTOGENE’S LATEST SCIENTIFIC PUBLICATIONS & WEBINARS

NEW CentoXome®: convirtiendo nuestra experiencia en su ventaja

Los oradores del webinar, la Dra. Pilar Guatibonza, Clinical Genetic Liaison CENTOGENE, y…

Webinar with topic WES, NGS, Mutation Database
Register

NEW CentoXome® – Turning Our Expertise Into Your Advantage

Dr. Aida Bertoli-Avella and Dr. Jorge Pinto-Pasto provide you with an exclusive look into…

Webinar with topic WES, NGS, Mutation Database
Register

Biomarker-Based Monitoring of Treatment Efficacy

The value of most metabolic biomarkers is restricted to diagnostic settings. A few…

Article with topic Biomarker
Read more

Collaborative Discovery of Gene-Disease Associations

The delineation of novel genetic disorders is facilitated by the formation of global…

Article with topic WES, WGS, Mutation Database, Neurology
Read more

COVID-19 and Parkinson’s Disease

As one of the company’s priority diseases, CENTOGENE is continuously carrying out research…

Article with topic Neurology, Covid-19 Testing
Read more

Sharing Diagnostic Insights to Support Rare Disease Patients

Defining a disorder’s complete clinical spectrum requires a detailed description of large…

Article with topic WES, WGS, Mutation Database, Neurology
Read more

Multiomic Characterization of Rare Disease Patients

Applying a multiomic approach to rare genetic diseases has great potential to…

Article with topic Biomarker
Read more

Improving Diagnostic Options for Rare Diseases

A diagnostic strategy for rare diseases based on a combination of standard laboratory…

Article with topic Biomarker, Metabolic Disorders
Read more

Modifiers of Genetic Disease

Therapeutic strategies for monogenic diseases may be derived from the identification and…

Article with topic WES, WGS, Mutation Database, Neurology
Read more

A Novel Genetic Cause for Autoinflammation

Genetic inflammatory disorders are quite rare, particularly those presenting with a…

Article with topic WES, WGS, Mutation Database
Read more

Company Newsletter

Keep up to date with the latest scientific insights and rare disease news
with your monthly digital edition of CentoBrief

Subscribe Now

CENTOGENE Reports Second Quarter 2021 Financial Results

Strong Revenues and Steady Return to Core Business Growth; Surpasses Milestone of 200 Scientific Publications, Highlighting Value of Bio/Databank

CAMBRIDGE,...

 Read more
Centogene,

CENTOGENE to Announce Second Quarter 2021 Financial Results on September 7, 2021

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, September 1, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...

 Read more
Centogene,

CENTOGENE Appoints Patrice P. Denèfle as Chief Scientific Officer to Lead Its Data-Driven Approach to Reinvent Rare Disease Drug Discovery and Development

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, July 27, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...

 Read more
Centogene,

CENTOGENEs CentoKit-19™ Abstrich-Set für einen Coronavirus-PCR-Test ist nun auch mit Videobegleitung durch den Telemedizin-Anbieter Kry buchbar – bequem zuhause bleiben und mit gültigem Testnachweis direkt ins Flugzeug

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 19. Juli 2021

  • Unterstützung per Video: Der Rachenabstrich und die Verpackung der Probe wird durch...
 Read more
Centogene,

CENTOGENE Announces Shareholders Approve All Resolutions at Annual General Meeting

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, June 25, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...

 Read more
Centogene,

CENTOGENE eröffnet Corona Test Center am Flughafen München und bietet dort unter anderem einen 1-Stunden-PCR-Test für Geschäftsreisende und Kurzentschlossene an

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 24. Juni 2021

  • CENTOGENE baut sein Netzwerk an SARS-CoV-2-Testcentern in deutschen Innenstädten und an...
 Read more
Centogene,

CENTOGENE Sets Mission to Enable the Cure of 100 Rare Diseases Within the Next 10 Years

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 22, 2021 (GLOBE NEWSWIRE)

Highlights strategic priorities to lead data-driven insights creation for rare...

 Read more
Centogene,

CENTOGENE Reports First Quarter 2021 Financial Results in the Lead Up to Virtual Investor Event

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, June 16, 2021 (GLOBE NEWSWIRE)

Further signs of recovery in the core rare disease business

Recorded...

 Read more
Centogene,

Angebot von SARS-CoV-2-PCR-Tests im Süden von Frankfurt: CENTOGENE eröffnet Walk-In-Corona Testcenter in Weiterstadt

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 16. Juni 2021

  • CENTOGENE, ein etablierter Anbieter von umfassenden SARS-CoV-2-Testslösungen, eröffnet...
 Read more
Centogene,